@article {5380,
	title = {Risk of endstage liver disease in HIV-viral hepatitis co-infected persons in North America from the early to modern antiretroviral therapy eras.},
	journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
	year = {2016},
	month = {2016 Aug 9},
	abstract = {  HIV-infected patients co-infected with Hepatitis B (HBV) and C (HCV) viruses are at increased risk of endstage liver disease (ESLD). Whether modern antiretroviral therapy has reduced ESLD risk is unknown.},
	issn = {1537-6591},
	doi = {10.1093/cid/ciw531 },
	author = {Klein, Marina B and Althoff, Keri N and Jing, Yuezhou and Lau, Bryan and Kitahata, Mari and Lo Re, Vincent and Kirk, Gregory D and Hull, Mark and Kim, H Nina and Sebastiani, Giada and Moodie, Erica and Silverberg, Michael J and Sterling, Timothy R and Thorne, Jennifer E and Cescon, Angela and Napravnik, Sonia and Eron, Joe and Gill, M John and Justice, Amy and Peters, Marion G and Goedert, James and Mayor, Angel and Thio, Chloe L and Cachay, Edward R and Moore, Richard}
}
